Results 31 to 40 of about 281,391 (223)

Rikkunshito for Preventing Chemotherapy-Induced Nausea and Vomiting in Lung Cancer Patients: Results from 2 Prospective, Randomized Phase 2 Trials

open access: yesFrontiers in Pharmacology, 2018
The herbal medicine rikkunshito has the potential to improve chemotherapy-induced nausea and vomiting (CINV) by stimulating ghrelin secretion. We aimed to evaluate the efficacy and safety of rikkunshito in preventing CINV for patients with lung cancer ...
Toshiyuki Harada   +17 more
doaj   +1 more source

Predicting Postoperative Nausea And Vomiting Using Machine Learning: A Model Development and Validation Study [PDF]

open access: yesarXiv, 2023
Background: Postoperative nausea and vomiting (PONV) is a frequently observed complication in patients undergoing surgery under general anesthesia. Moreover, it is a frequent cause of distress and dissatisfaction during the early postoperative period. The tools used for predicting PONV at present have not yielded satisfactory results.
arxiv  

Frequency of Predisposing Factor of Nausea and Vomiting After Chest Surgery Under General Anaesthesia [PDF]

open access: yes, 2019
Background: Postoperative nausea and vomiting are common and distressing postsurgical symptoms. These symptoms are of particular concern in outpatient surgery because they may require additional direct resources, such as supplies and antiemetic ...
Bhatti, S. U. (Sami)   +5 more
core   +2 more sources

The Effect of Ginger and Cinnamon Consumption on Chemotherapy-Induced Nausea and Vomiting: A Double-Blind Randomized Clinical Trial [PDF]

open access: yesمجله دانشکده پزشکی اصفهان, 2022
Background: Chemotherapy-induced nausea and vomiting (CINV) is a major side effect seen among cancer patients under chemotherapy. Ginger (Zingiber officinale) and cinnamon (Cinnamomum zeylanicum) are among the traditional antiemetic drugs.
Mohamad Amin   +3 more
doaj   +1 more source

Measurement of nausea [PDF]

open access: yesJournal of Pain and Symptom Management, 1989
Dr. Mary Barnes’ has written an excellent review on “nausea and vomiting in the patient with advanced cancer.” In addition to the pain suffered by the majority of cancer patients, nausea caused by chemotherapy, narcotics, or the disease process itself represents another torment to be endured by almost 50% of cancer patients.
openaire   +2 more sources

Socio-demographic and pregnancy-related characteristics associated with prenatal distress: a Turkish study

open access: yesCentral European Journal of Nursing and Midwifery, 2019
Aim: This study aimed to determine socio-demographic and pregnancy-related characteristics associated with prenatal distress. Design: Cross-sectional study.
Emel Bahadir Yilmaz
doaj   +1 more source

Attention2AngioGAN: Synthesizing Fluorescein Angiography from Retinal Fundus Images using Generative Adversarial Networks [PDF]

open access: yes, 2020
Fluorescein Angiography (FA) is a technique that employs the designated camera for Fundus photography incorporating excitation and barrier filters. FA also requires fluorescein dye that is injected intravenously, which might cause adverse effects ranging from nausea, vomiting to even fatal anaphylaxis.
arxiv   +1 more source

Management of chemotherapy induced emesis [PDF]

open access: yesArchive of Oncology, 2004
Important progress has been achieved in the last few years in the prevention of chemotherapy-induced nausea and vomiting thanks to the introduction in clinical practice first of the 5-HT3 antagonists and of the NK1 antagonists more recently.
Roila Fausto
doaj   +1 more source

Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy. [PDF]

open access: yes, 2011
Our study shows that in Indonesian cancer patients treated with highly cytostatic emetogenic, carriership of the CTG haplotype of the ABCB1 gene is related to an increased risk of delayed chemotherapy-induced nausea and ...
Baak-Pablo, Renee F   +8 more
core   +2 more sources

Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial. [PDF]

open access: yes, 2018
ObjectiveTo better understand the utility of using pain freedom and most bothersome headache-associated symptom (MBS) freedom as co-primary endpoints in clinical trials of acute migraine interventions.BackgroundAdhesive dermally applied microarray (ADAM)
Dodick, David W   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy